# Nature prescription for patients with chronic respiratory diseases

**Authors:** Marilyn Urrutia-Pereira, Dirceu Solé, Tonya Winders, Verónica Riquelme Martinez, Rovana Kinas Bueno, Debora da Cruz Payão Pellegrini, Jeferson Rafael Bueno, Felipe Haniel Derré Torres, Camila Girotto Alberti, Bruna Simoneto Marques, Barbara Angelo de Moraes, Ana Clara Sevá, Daniel Barba Kaestner, Herberto Jose Chong-Neto, Tari Haahtela

PMC · DOI: 10.1016/j.waojou.2026.101351 · The World Allergy Organization Journal · 2026-02-27

## TL;DR

This paper explores how spending time in nature can help people with chronic respiratory diseases like asthma and COPD.

## Contribution

The paper introduces a scoping review and protocol for evaluating nature prescriptions in respiratory disease management.

## Key findings

- Regular exposure to green spaces increases physical activity and improves lung function.
- Nature prescriptions reduce stress, anxiety, and the need for rescue medication.
- Integrating nature into care is suggested as a safe and accessible health strategy.

## Abstract

Nature prescription is a relatively new clinical approach consisting of recommendations of exposure to natural environments as a complementary intervention to support health. Especially in the treatment of asthma and chronic obstructive pulmonary disease (COPD), increased connection to wider nature appears useful. Nature prescription integrates green space practices such as outdoor walks, other low-grade exercise, contemplation, and mindfulness. We have prepared a scoping review of the relevant literature on nature prescription for patients with chronic respiratory diseases, considering population studies but also clinical experience. The results indicate that regular exposure to green space contributes to increased physical activity, reduced stress and anxiety, improved lung function, reduced need for rescue medication, and better adherence to treatment. A protocol is also proposed to evaluate these outcomes. We conclude that integrating the use of green space and natural outdoor elements into multidisciplinary care represents an accessible, safe enough, and potentially effective strategy to promote respiratory health.

## Linked entities

- **Diseases:** asthma (MONDO:0004979), chronic obstructive pulmonary disease (MONDO:0005002), COPD (MONDO:0005002)

## Full-text entities

- **Genes:** ALK (ALK receptor tyrosine kinase) [NCBI Gene 238] {aka ALK1, CD246, NBLST3}, IGHE (immunoglobulin heavy constant epsilon) [NCBI Gene 3497] {aka IgE}
- **Diseases:** death (MESH:D003643), CRD (OMIM:120970), burnout (MESH:D002055), Allergic Rhinitis (MESH:D065631), immune dysfunction (MESH:D007154), cough (MESH:D003371), bone problems (MESH:D001847), AR (MESH:D013734), depression (MESH:D003866), heart disease (MESH:D006331), Allergy (MESH:D004342), chronic ill health (MESH:D000071069), chronic diseases (MESH:D002908), muscle tension (MESH:D018781), airway inflammation (MESH:D007249), Chronic Respiratory Diseases (MESH:D012140), insomnia (MESH:D007319), dyspnea (MESH:D004417), diabetes (MESH:D003920), lung diseases (MESH:D008171), dysbiosis (MESH:D064806), Asthma (MESH:D001249), Anxiety (MESH:D001007), obesity (MESH:D009765), COPD (MESH:D029424), Chronic noncommunicable diseases (MESH:D000073296), lung inflammation (MESH:D011014), immune-mediated diseases (MESH:C567355), chronic fatigue (MESH:D015673), hyperactivity (MESH:D006948), Disorders (MESH:D009358), sympathetic nervous system hyperactivity (MESH:D001342)
- **Chemicals:** O3 (MESH:D010126), PM2.5 (-), alcohol (MESH:D000438), glucose (MESH:D005947), O2 (MESH:D010100), NO2 (MESH:D009585), cortisol (MESH:D006854), triglycerides (MESH:D014280), essential oils (MESH:D009822), phytoncides (MESH:C000711779), volatile organic compounds (MESH:D055549), cholesterol (MESH:D002784)
- **Species:** Felis catus (cat, species) [taxon 9685], Homo sapiens (human, species) [taxon 9606], Nicotiana tabacum (American tobacco, species) [taxon 4097]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12966752/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12966752/full.md

## References

118 references — full list in the complete paper: https://tomesphere.com/paper/PMC12966752/full.md

---
Source: https://tomesphere.com/paper/PMC12966752